Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nootropics as Cognitive Enhancers: Types, Dosage and Side Effects of Smart Drugs
Matěj Malík, Pavel Tlustoš
Nutrients (2022) Vol. 14, Iss. 16, pp. 3367-3367
Open Access | Times Cited: 61

Showing 1-25 of 61 citing articles:

Nootropic Herbs, Shrubs, and Trees as Potential Cognitive Enhancers
Matěj Malík, Pavel Tlustoš
Plants (2023) Vol. 12, Iss. 6, pp. 1364-1364
Open Access | Times Cited: 24
Unauthorized ingredients in “nootropic” dietary supplements: A review of the history, pharmacology, prevalence, international regulations, and potential as doping agents
Karol Jędrejko, Oliver Catlin, Timothy Stewart, et al.
Drug Testing and Analysis (2023) Vol. 15, Iss. 8, pp. 803-839
Closed Access | Times Cited: 18
Comprehensive Review of Nutraceuticals against Cognitive Decline Associated with Alzheimer’s Disease
Edwin E. Reza-Zaldívar, Daniel A. Jacobo‐Velázquez
ACS Omega (2023) Vol. 8, Iss. 39, pp. 35499-35522
Open Access | Times Cited: 13
Development of White Cabbage, Coffee, and Red Onion Extracts as Natural Phosphodiesterase-4B (PDE4B) Inhibitors for Cognitive Dysfunction: In Vitro and In Silico Studies
Nazir Ahmad, Kaisun Nesa Lesa, Navista Sri Octa Ujiantari, et al.
Advances in Pharmacological and Pharmaceutical Sciences (2024) Vol. 2024, pp. 1-39
Open Access | Times Cited: 5
Docosahexaenoic Acid (DHA), Vitamin D3, and Probiotics Supplementation Improve Memory, Glial Reactivity, and Oxidative Stress Biomarkers in an Aluminum-Induced Cognitive Impairment Rat Model
Paulinna Faccinetto-Beltrán, Edwin E. Reza-Zaldívar, David Alejandro Curiel-Pedraza, et al.
ACS Omega (2024) Vol. 9, Iss. 19, pp. 21221-21233
Open Access | Times Cited: 4
Editorial: Neurodegeneration and cognitive impairment after traumatic brain injury
Tao Liu, Li Ma, Yu Chen, et al.
Frontiers in Neuroscience (2025) Vol. 19
Open Access
Effect of a Plant-Based Nootropic Supplement on Perceptual Decision-Making and Brain Network Interdependencies: A Randomised, Double-Blinded, and Placebo-Controlled Study
David Ó’Reilly, Joshua Bolam, Ioannis Delis, et al.
Brain Sciences (2025) Vol. 15, Iss. 3, pp. 226-226
Open Access
Ginkgo Biloba as a niche theme cognitive enhancer agent, 1420 dokumen of Scopus database. A bibliometric study from 1988 to 2024
ARMAN YURISALDI SALEH, Dwi Arwandi Yogi Saputra, Riezky Valentina, et al.
F1000Research (2025) Vol. 14, pp. 275-275
Open Access
How are sports drinks and soft drinks different from energy drinks?
Dan Stefan, Eliza Cinteză
Elsevier eBooks (2025), pp. 21-32
Closed Access
The mechanistic role of piracetam in the management of vascular dementia
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Duaa Eliwa, et al.
Behavioural Brain Research (2025), pp. 115551-115551
Closed Access
The Dark Side of “Smart Drugs”: Cognitive Enhancement vs. Clinical Concerns
Mariarosaria Ingegneri, Erika Smeriglio, Younes Zebbiche, et al.
Toxics (2025) Vol. 13, Iss. 4, pp. 247-247
Open Access
The efficacy and toxicity equilibrium of emodin for liver injury: A bidirectional meta-analysis and machine learning
Sihan Hu, Xiaochuan Guo, Le-Mai Tu, et al.
Phytomedicine (2025), pp. 156650-156650
Closed Access
New Trends in Peptide Therapies: Perspectives and Implications for Clinical Neurosciences
Wilfredo López-Ojeda, Robin A. Hurley
Journal of Neuropsychiatry (2025) Vol. 37, Iss. 2, pp. A6-101
Closed Access
Acute Supplementation of Soluble Mango Leaf Extract (Zynamite® S) Improves Mental Performance and Mood: A Randomized, Double-Blind, Placebo-Controlled Crossover Study
Yolanda Castellote‐Caballero, Ana Beltrán-Arranz, Agustín Aibar‐Almazán, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 4, pp. 571-571
Open Access
Advances in Nanoparticles in Targeted Drug Delivery- A Review
Safiul Islam, Md Mir Shakib Ahmed, Mohammad Aminul Islam, et al.
Results in Surfaces and Interfaces (2025), pp. 100529-100529
Open Access
Oxiracetam ameliorates neurological function after traumatic brain injury through competing endogenous RNA regulatory network
Liyi Wang, Han Guo, Weidong Zhao, et al.
Psychopharmacology (2025)
Closed Access
Synthesis, docking, and biological evaluation of novel 1-benzyl-4-(4-(R)-5-sulfonylidene-4,5-dihydro-1H-1,2,4-triazol-3-yl)pyrrolidin-2-ones as potential nootropic agents
Anton Semenets, Мarharyta Suleiman, А. І. Федосов, et al.
European Journal of Medicinal Chemistry (2022) Vol. 244, pp. 114823-114823
Closed Access | Times Cited: 17
Targeting microbiota–immune–synaptic plasticity to explore the effect of tea polyphenols on improving memory in the aged type 2 diabetic rat model
Chenhui Lv, Le Cheng, Wenjuan Feng, et al.
Nutritional Neuroscience (2024), pp. 1-17
Closed Access | Times Cited: 3
Preclinical Studies of Canagliflozin, a Sodium-Glucose Co-Transporter 2 Inhibitor, and Donepezil Combined Therapy in Alzheimer’s Disease
Gabriela Dumitrița Stanciu, Daniela Carmen Ababei, Carmen Solcan, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 11, pp. 1620-1620
Open Access | Times Cited: 8
Neuropsychopharmacological Induction of (Lucid) Dreams: A Narrative Review
Abel A. Oldoni, André Demambre Bacchi, Fúlvio Rieli Mendes, et al.
Brain Sciences (2024) Vol. 14, Iss. 5, pp. 426-426
Open Access | Times Cited: 2
Assessment of the impact of neuro-linguistic programming on primary Schoolchildren's intellectual capacity
Marwa Manana, Sarah Tarhini, Diana Ghanem, et al.
Social Sciences & Humanities Open (2024) Vol. 10, pp. 100966-100966
Open Access | Times Cited: 2
Alcohol, flexible behavior, and the prefrontal cortex: Functional changes underlying impaired cognitive flexibility
Kathryn E. Nippert, Courtney P. Rowland, Elena M. Vazey, et al.
Neuropharmacology (2024) Vol. 260, pp. 110114-110114
Closed Access | Times Cited: 2
Pharmacological treatments for vascular dementia: a systematic review and Bayesian network meta-analysis
Chun Dang, Qinxuan Wang, Yijia Zhuang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 2
Neurovascular glial unit: A target of phytotherapy for cognitive impairments
Lixia Chen, Yilan Zhen, Xuncui Wang, et al.
Phytomedicine (2023) Vol. 119, pp. 155009-155009
Closed Access | Times Cited: 6
Oxiracetam alleviates anti-inflammatory activity and ameliorates cognitive impairment in the early phase of traumatic brain injury
Dong Hyuk Youn, Sung Woo Han, Jong-Tae Kim, et al.
Acta Neurochirurgica (2023) Vol. 165, Iss. 8, pp. 2201-2210
Closed Access | Times Cited: 5
Page 1 - Next Page

Scroll to top